Resources

The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have issued a joint position statement emphasizing patient-specific treatment of hyperglycemia in persons with type 2 diabetes….

HbA1c levels rise rapidly in the year before a diagnosis of type 2 diabetes….

The long-term benefit for type 2 patients using metformin along with insulin is….

The FDA announced that physicians must not prescribe antihypertensive drugs containing aliskiren….

Insulin-treated patients with type 2 diabetes who are noncompliant with their medication or clinic appointments face increased all-cause mortality….

Controversy over the risk of diabetes associated with high-dose statins has prompted investigators across a wide range of studies to delve back into their data sets to look for a diabetes signal….

A new study found an association between being diabetic and overweight, and increased risk of breast cancer….

Yet another study has found that bariatric surgery is a better diabetes treatment in obese patients than medical therapy, researchers said, confirming results from other recent trials….

The agency issued a complete response letter for new drug applications of alogliptin and a combination drug that pairs alogliptin with another Takeda drug, Actos….

European regulators backed approval of a new diabetes drug from AstraZeneca and Bristol-Myers Squibb, in a decision that contrasts with its failure to win approval in the US….